☆ 4.4 Editorial Material

Modern Electroconvulsive Therapy Vastly Improved yet Greatly Underused

JAMA PSYCHIATRY (2017)

Get Full Text
Add to Collection

Journal

JAMA PSYCHIATRY
Volume 74, Issue 8, Pages 779-780

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/jamapsychiatry.2017.1670

Keywords

-

Categories

Psychiatry

Funding

  1. Brainsway
  2. Cyberonics
  3. Cervel Neurotech/NeoStim
  4. Magstim
  5. NeoSync
  6. NeuroPace
  7. Cambridge Neuroscience
  8. Eli Lilly and Company
  9. Forest Laboratories
  10. Hoffman-La Roche
  11. Interneuron Pharmaceuticals
  12. Novartis International
  13. Pfizer
  14. Warner-Lambert
  15. Wyeth-Ayerst

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.